Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

A.Fib Emergency Department Study Atrial Fibrillation

Completed

Conditions: Atrial Fibrillation

First Posted Date: 2017-04-25

Last Posted Date: 2019-02-15

Lead Sponsor: Queen's University

Target Recruit Count: 297

Registration Number: NCT03127085

Locations: 🇨🇦
Kingston Health Sciences Centre - Kingston General Hospital Site, Kingston, Ontario, Canada

TKA Using Patient-Specific Instrumentation

Not Applicable

Withdrawn

Conditions: Knee Osteoarthritis

Interventions: Device: Stryker ShapeMatch Technology
Device: Stryker Triathlon Custom Fit Knee

First Posted Date: 2017-04-18

Last Posted Date: 2018-04-06

Lead Sponsor: Queen's University

Registration Number: NCT03117959

Locations: 🇨🇦
Hotel Dieu Hospital, Kingston, Ontario, Canada

Affective Attentional Bias Training In Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Affective training
Behavioral: Sham training

First Posted Date: 2017-04-11

Last Posted Date: 2018-08-28

Lead Sponsor: Queen's University

Target Recruit Count: 40

Registration Number: NCT03106883

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Phase 2

Active, not recruiting

Conditions: Lung Cancer Metastatic

Interventions: Drug: Durvalumab
Drug: Tremelimumab
Drug: Platinum-Based Drug

First Posted Date: 2017-02-17

Last Posted Date: 2025-05-14

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 301

Registration Number: NCT03057106

Locations: 🇦🇺
Campbelltown Hospital, Campbelltown, New South Wales, Australia
🇦🇺
Coffs Habour Health Campus - NCCI, Coffs Harbour, New South Wales, Australia
🇦🇺
Concord Repatriation General Hospital, Concord, New South Wales, Australia

and more 46 locations

A Comparison of Cognitive Training Approaches in Psychotic Disorders

Not Applicable

Completed

Conditions: Psychotic Disorders

Interventions: Behavioral: Cognitive Remediation - Perceptual Training
Behavioral: Cognitive Remediation - Executive Training

First Posted Date: 2017-01-18

Last Posted Date: 2018-11-14

Lead Sponsor: Queen's University

Target Recruit Count: 70

Registration Number: NCT03024203

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases

Phase 2

Terminated

Conditions: Melanoma
Brain Metastases

Interventions: Drug: Dabrafenib
Drug: Trametinib

First Posted Date: 2016-11-28

Last Posted Date: 2021-08-20

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 6

Registration Number: NCT02974803

Locations: 🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦
Odette Cancer Centre, Toronto, Ontario, Canada

and more 3 locations

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Not Applicable

Active, not recruiting

Conditions: Prostate Carcinoma

Interventions: Radiation: High dose rate brachytherapy
Radiation: Low dose rate brachytherapy

First Posted Date: 2016-11-09

Last Posted Date: 2025-04-15

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 334

Registration Number: NCT02960087

Locations: 🇨🇦
London Health Sciences Centre Research Inc., London, Ontario, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
🇨🇦
Odette Cancer Centre, Toronto, Ontario, Canada

and more 4 locations

The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER

Not Applicable

Completed

Conditions: Acute Coronary Syndrome
Carotid Artery Plaque
Chest Pain

Interventions: Other: Focused vascular ultrasound of the carotid arteries

First Posted Date: 2016-10-27

Last Posted Date: 2019-01-23

Lead Sponsor: Queen's University

Target Recruit Count: 326

Registration Number: NCT02947360

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Palbociclib

First Posted Date: 2016-09-19

Last Posted Date: 2025-05-13

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 19

Registration Number: NCT02905318

Locations: 🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦
London Regional Cancer Program, London, Ontario, Canada

and more 4 locations

Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours

Phase 2

Completed

Conditions: Advanced Rare Tumours

Interventions: Drug: Durvalumab
Drug: Tremelimumab

First Posted Date: 2016-08-25

Last Posted Date: 2025-03-25

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 140

Registration Number: NCT02879162

Locations: 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦
BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada

and more 10 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy